Filter
1318
Filtered Results: 1318
Text search:
Manufacturing
Featured
Recommendations
101
New Publications
315
Language
Document type
No document type
612
Studies & Reports
291
Guidelines
177
Strategic & Response Plan
77
Manuals
64
Fact sheets
54
Situation Updates
14
Training Material
12
Resource Platforms
8
Brochures
4
Infographics
2
Online Courses
2
Videos
1
Countries / Regions
Global
61
India
54
Kenya
43
Uganda
26
Ethiopia
25
Sierra Leone
24
Nigeria
24
Ghana
24
Nepal
24
Western and Central Europe
22
Africa
21
Zambia
20
Rwanda
20
South Africa
19
Myanmar / Burma
17
Tanzania
16
Bangladesh
16
Ukraine
15
Lesotho
15
Liberia
14
Syria
14
West and Central Africa
14
Philippines
13
Malawi
13
Namibia
13
South–East Asia Region
12
East and Southern Africa
11
Botswana
10
Latin America and the Carribbean
10
Zimbabwe
9
Guinea
8
Congo, Democratic Republic of
8
Haiti
7
Indonesia
7
Eswatini/ Swaziland
7
Pakistan
5
Benin
5
Middle East and North Africa
5
Asia
5
Eastern Europe
5
Russia
5
USA
4
South Sudan
4
Cambodia
4
Thailand
4
Mozambique
4
Sri Lanka
4
Eastern Europe and Central Asia
4
Senegal
3
Cameroon
3
Jordan
3
Germany
3
Argentina
3
Yemen
3
Albania
3
Tajikistan
3
Moldova
3
United Kingdom
3
Afghanistan
2
Chad
2
China
2
Sudan
2
Central African Republic
2
Colombia
2
Western Pacific Region
2
Laos
2
Turkmenistan
2
Mauritius
2
Burkina Faso
1
Côte d’Ivoire / Ivory Coast
1
Iraq
1
Lebanon
1
Turkey
1
Egypt
1
Peru
1
Brazil
1
Serbia
1
Ecuador
1
Angola
1
Madagascar
1
Solomon Islands
1
Venezuela
1
Mongolia
1
Southern Africa
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Vietnam
1
Maldives
1
Portugal
1
Spain
1
Belarus
1
Israel
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
495
Clinical Guidelines
78
Public Health
61
Key Resources
57
Pharmacy & Technologies
43
Women & Child Health
25
Capacity Building
10
Toolboxes
COVID-19
174
Pharmacy
102
AMR
94
HIV
82
Planetary Health
81
TB
43
Mental Health
42
Rapid Response
34
Ebola
31
Conflict
29
Global Health Education
26
NCDs
25
Disability
23
NTDs
21
Specific Hazards
19
Health Financing Toolbox
18
Natural Hazards
16
Caregiver
12
Refugee
10
Polio
9
Cholera
8
Zika
3
Typhoon
1
Updated version – September 2020
The COVID-19 pandemic is affecting everyone. Globally, millions of people have been infected with the virus, while hundreds of thousands have lost their lives. In Moldova, the pandemic is placing an ever-increasing pressure on the health care and social protectio...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Intra-African migration remains a dominant trend in contemporary African migration. The Strategy frames the Organization’s new orientation with Africa at policy and strategic levels. It is consistent with the goals and objectives of the Global Compact for Safe, Orderly and Regular Migration (GCM) ...
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f...
This operation update provides a summary of key results achieved against the IFRC Syria Complex Emergency Plan of Action covering 13-month period, from 1 June 2019 to 30 June 2020.
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
La publication fournit une vue d'ensemble et une analyse des instruments internationaux qui établissent des normes relatives à l'utilisation des antimicrobiens dans les secteurs humain, animal et végétal, et à leur rejet dans l'environnement. L'objectif de ce document est d'identifier les instr...
The purpose of this guide is to offer recommendations for improving the implementation of non‑pharmacological public health measures during the COVID-19 response and compliance with these measures by population groups in situations of vulnerability. This requires determining the main barriers to i...
MMWR Morb Mortal Wkly Rep. ePub: 4 December 2020. DOI: http://dx.doi.org/10.15585/mmwr.mm6949e2
This guide is available in English, French, Spanish, Russian, Arabic and Chinese
This guide consolidates COVID-19 guidance for human resources for health managers and policy-makers at national, subnational and facility levels to design, manage and preserve the workforce necessary to manage the COVI...
10 December 2020
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
This guide provides an overview of the major elements that must be considered before, during and after the implementation of antigen-detecting rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2. This guide is complementary to policy guidance issued by the World Health Organization (WHO). The guide may ...
